Table 1.

Reports of RVO in patients actively infected with or recently recovered from COVID-19

Report	Age/gender	Risk factors	Presenting VA	Ocular features	COVID PCR	COVID antibodies	Hospitalized	Clinical course
CRVO
Yahalomi et al. [7]	33/M	None	20/25	Venous tortuosity, mild IRH; perfused	Negative	Positive	No	Fatigue, dry cough, SOB
Gaba et al. [9]	40/M	HTN	20/20 OD, 20/60 OS	Bilateral CRVO; multiple CWS with scant IRH OD, peripapillary and parafoveal IRH OS; no FA reported	Positive	Not reported	Yes	Severe COVID pneumonia, RLE DVT; therapeutic anticoagulation
Lorca et al. [10]	30/F	DM	20/30 OD, 20/30 OS	Bilateral CRVO; diffuse IRH OU, mild VH OU; patchy CNP OU	Not reported	Not reported	Yes	COVID pneumonia
Invernizzi et al. [11]	54/F	None	20/40	Impending CRVO, perivenular whitening with IRH, +APD; no FA reported	Positive	Not reported	Yes	Mild COVID pneumonia; IV methylprednisolone [initial concern for optic neuritis]
Walinjkar et al. [8]	17/F	PCOS	20/80	Dense diffuse IRH, severe CME with SRF; no FA reported	Negative	Positive	No	COVID pneumonia
BRVO
Sheth et al. [12]	52/M	None	20/200	Inferior HRVO with superonasal BRVO; dense IRH with CWS, severe CME with SRF; diffuse venous leakage	Positive	Not reported	Yes	Fever (no further information]

IRH, intraretinal hemorrhage; CWS, cottonwool spot; FA, fluorescein angiography; VH, vitreous hemorrhage; CNP, capillary nonperfusion; APD, afferent pupillary defect; CME, cystoid macular edema; SRF, subretinal fluid; HRVO, hemiretinal vein occlusion; BRVO, branch retinal vein occlusion; SOB, shortness of breath; RLE, right lower extremity; DVT, deep vein thrombosis; CRVO, central retinal vein occlusion; PCOS, polycystic ovarian syndrome.